Drs. Verstovsek and Rafandi present data on Incyte's JAK2 Inhibitor, INCB018424, currently being tested in MPD patients
Dr. Tefferi presents research on JAK2 germline and survival in MF patients
Favorable review of Cytopia by Mayo's IRB and FDA for their JAK2 Inhibitor CYT387 trial now under way
SBIO to present data on their JAK2 Inhibitor SB1518, in Phase I
Please check back for updates
Get free, timely information on living with an MPN.
